Mona Toussaint-Andre

NPI: 1972279891
Total Payments
$2,734
2024 Payments
$363.95
Companies
13
Transactions
136
Medicare Patients
31
Medicare Billing
$2,870

Payment Breakdown by Category

Food & Beverage$2,616 (95.7%)
Education$118.41 (4.3%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $2,616 133 95.7%
Education $118.41 3 4.3%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $567.96 38 $0 (2023)
Teva Pharmaceuticals USA, Inc. $325.24 17 $0 (2023)
ITI, Inc. $301.05 22 $0 (2023)
Alkermes, Inc. $297.34 11 $0 (2024)
Otsuka America Pharmaceutical, Inc. $289.65 14 $0 (2023)
Janssen Pharmaceuticals, Inc $237.49 8 $0 (2023)
Neurocrine Biosciences, Inc. $154.18 6 $0 (2022)
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $124.99 1 $0 (2024)
Vanda Pharmaceuticals Inc. $124.99 1 $0 (2024)
Sunovion Pharmaceuticals Inc. $124.78 7 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $363.95 3 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($124.99)
2023 $375.13 16 Janssen Pharmaceuticals, Inc ($117.48)
2022 $1,976 116 ABBVIE INC. ($534.18)
2021 $19.38 1 Neurocrine Biosciences, Inc. ($19.38)

All Payment Transactions

136 individual payment records from CMS Open Payments — Page 1 of 6

Date Company Product Nature Form Amount Type
10/25/2024 Alkermes, Inc. VIVITROL (Drug) Food and Beverage In-kind items and services $113.97 General
Category: CNS
09/19/2024 Vanda Pharmaceuticals Inc. FANAPT (Drug) Food and Beverage Cash or cash equivalent $124.99 General
Category: SCHIZOPHRENIA
06/13/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $124.99 General
Category: PSYCHIATRY
06/16/2023 Indivior Inc. PERSERIS (Drug) Food and Beverage In-kind items and services $20.92 General
Category: BH
06/14/2023 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $17.04 General
Category: Central Nervous System
06/09/2023 Teva Pharmaceuticals USA, Inc. Austedo XR (Drug) Food and Beverage In-kind items and services $19.89 General
Category: Central Nervous System
06/08/2023 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $13.60 General
Category: PSYCHIATRY
05/12/2023 Alkermes, Inc. ARISTADA (Drug), ARISTADA, ARISTADA Food and Beverage In-kind items and services $26.92 General
Category: CNS
05/12/2023 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Food and Beverage In-kind items and services $24.03 General
Category: Neuroscience
05/05/2023 Lundbeck LLC REXULTI (Drug) Food and Beverage Cash or cash equivalent $14.73 General
Category: PSYCHIATRY
04/29/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $27.97 General
Category: PSYCHIATRY
03/15/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $18.93 General
Category: NEUROSCIENCE
03/08/2023 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug) Education In-kind items and services $62.99 General
Category: Neuroscience
03/03/2023 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $13.23 General
Category: PSYCHIATRY
02/03/2023 Otsuka America Pharmaceutical, Inc. ABILIFY MAINTENA (Drug), REXULTI Food and Beverage In-kind items and services $26.32 General
Category: PSYCHIATRY
02/03/2023 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $21.59 General
Category: Central Nervous System
01/25/2023 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $21.66 General
Category: Central Nervous System
01/13/2023 Janssen Pharmaceuticals, Inc INVEGA SUSTENNA (Drug), INVEGA TRINZA Food and Beverage In-kind items and services $30.46 General
Category: Neuroscience
01/06/2023 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $14.85 General
Category: NEUROSCIENCE
11/18/2022 Teva Pharmaceuticals USA, Inc. AUSTEDO (Drug) Food and Beverage In-kind items and services $22.24 General
Category: Central Nervous System
11/16/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $14.63 General
Category: PSYCHIATRY
10/20/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $15.53 General
Category: NEUROSCIENCE
09/22/2022 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $19.36 General
Category: PSYCHIATRY
09/20/2022 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $21.02 General
Category: NEUROSCIENCE
09/16/2022 ITI, Inc. CAPLYTA (Drug) Food and Beverage In-kind items and services $10.32 General
Category: PSYCHIATRY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 1 31 55 $15,125 $2,870
Total Patients
31
Total Services
55
Medicare Billing
$2,870
Procedure Codes
2

All Medicare Procedures & Services

2 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 17 28 $7,700 $1,563 20.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 14 27 $7,425 $1,307 17.6%

About Mona Toussaint-Andre

Mona Toussaint-Andre is a Psychiatric/Mental Health healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/19/2021. The National Provider Identifier (NPI) number assigned to this provider is 1972279891.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mona Toussaint-Andre has received a total of $2,734 in payments from pharmaceutical and medical device companies, with $363.95 received in 2024. These payments were reported across 136 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($2,616).

As a Medicare-enrolled provider, Toussaint-Andre has provided services to 31 Medicare beneficiaries, totaling 55 services with total Medicare billing of $2,870. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.

Practice Information

  • Specialty Psychiatric/Mental Health
  • Location Miami, FL
  • Active Since 08/19/2021
  • Last Updated 08/19/2021
  • Taxonomy Code 363LP0808X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1972279891

Products in Payments

  • VRAYLAR (Drug) $567.96
  • CAPLYTA (Drug) $426.04
  • AUSTEDO (Drug) $288.31
  • INVEGA SUSTENNA (Drug) $237.49
  • REXULTI (Drug) $184.92
  • INGREZZA (Drug) $154.18
  • ABILIFY MAINTENA (Drug) $133.06
  • FANAPT (Drug) $124.99
  • LATUDA (Drug) $124.78
  • VIVITROL (Drug) $113.97
  • PERSERIS (Drug) $108.23
  • ARISTADA (Drug) $102.41
  • LYBALVI (Drug) $80.96
  • CITALOPRAM (Drug) $50.08
  • Austedo XR (Drug) $36.93

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Psychiatric/Mental Health Doctors in Miami